<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03930108</url>
  </required_header>
  <id_info>
    <org_study_id>IndonesiaUAnes033</org_study_id>
    <nct_id>NCT03930108</nct_id>
  </id_info>
  <brief_title>Validity of SOFA Score as Predictor of Mortality in Critically-ill Burn Patients</brief_title>
  <official_title>Validity of Sequential Organ Failure Assessment (SOFA) Score as Predictor of Mortality in Critically-ill Burn Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      SOFA score is valid for mortality predictor for critically-ill patient in high care and
      intensive care burn unit
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 17, 2018</start_date>
  <completion_date type="Actual">February 17, 2019</completion_date>
  <primary_completion_date type="Actual">December 17, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SOFA score Discrimination</measure>
    <time_frame>30 days from admission</time_frame>
    <description>SOFA score ability to discriminate outcomes based on variable scores: PaO2/FiO2; MAP/vasoactive treatment; serum creatinine or 24-h diuresis; platelet count; serum bilirubin; GCS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SOFA score Calibration</measure>
    <time_frame>30 days from admission</time_frame>
    <description>SOFA score cutoff to predict outcome based on variable scores: PaO2/FiO2; MAP/vasoactive treatment; serum creatinine or 24-h diuresis; platelet count; serum bilirubin; GCS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation between SOFA score variables with outcome</measure>
    <time_frame>30 days from admission</time_frame>
    <description>Correlation between patient outcomes with each SOFA score variable: PaO2/FiO2; MAP/vasoactive treatment; serum creatinine or 24-h diuresis; platelet count; serum bilirubin; GCS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient outcome</measure>
    <time_frame>30 days from admission</time_frame>
    <description>Patient outcome within 30 days of admission to burn units: deceased or survived</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score: Partial Oxygen Pressure (PaO2)/ Fraction of Inspired Oxygen (FiO2)</measure>
    <time_frame>Day 1</time_frame>
    <description>The score for PaO2/FiO2 variable cutoff:
0 point for &gt;400 mmHg;
point for &lt;400 mmHg;
points for &lt;300 mmHg;
points for &lt;200 mmHg with respiratory support;
points for &lt;100 mmHg with respiratory support.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score: Mean Arterial Pressure (MAP) or vasoactive agent usage</measure>
    <time_frame>Day 1</time_frame>
    <description>The score for MAP or vasoactive agent usage variable cutoff:
0 point for MAP &gt;=70 mmHg;
point for MAP &lt;70 mmHg;
points for dopamine &lt;= 5 mcg/kg/min OR dobutamine any dose;
points for dopamine &gt;5 mcg/kg/min OR norepinephrine or epinephrine &lt;=0.1 mcg/kg/min;
points for dopamine &gt;15 mcg/kg/min OR norepinephrine or epinephrine &gt;0.1 mcg/kg/min.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score: Serum creatinine or 24-hour diuresis</measure>
    <time_frame>Day 1</time_frame>
    <description>The score for serum creatinine or 24-hour diuresis variable cutoff:
0 point for creatinine &lt;1.2 mg/dL;
point for creatinine 1.2 - 1.9 mg/dL;
points for creatinine 2.0 - 3.4 mg/dL;
points for creatinine 3.5 - 4.9 mg/dL OR diuresis &lt;500 mL/24h;
points for creatinine &gt;5.0 mg/dL OR diuresis &lt;200 mL/24h.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score: Platelet count</measure>
    <time_frame>Day 1</time_frame>
    <description>The score for platelet count variable cutoff:
0 point for &gt;=150 x10^3/mm^3;
point for &lt;150 x10^3/mm^3;
points for &lt;100 x10^3/mm^3;
points for &lt;50 x10^3/mm^3;
points for &lt;20 x10^3/mm^3.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score: Serum Bilirubin</measure>
    <time_frame>Day 1</time_frame>
    <description>The score for serum bilirubin variable cutoff:
0 point for &lt;1.2 mg/dL;
point for 1.2 - 1.9 mg/dL;
points for 2.0 - 5.9 mg/dL;
points for 6.0 - 11.9 mg/dL;
points for &gt;12.0 mg/dL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score: Glasgow Coma Scale (GCS)</measure>
    <time_frame>Day 1</time_frame>
    <description>The score for GCS variable cutoff:
0 point for 15;
point for 13 - 14;
points for 10 - 12;
points for 6 - 9;
points for &lt;6L.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">169</enrollment>
  <condition>Mortality Prediction</condition>
  <arm_group>
    <arm_group_label>Mortality outcome</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SOFA score</intervention_name>
    <description>Variables of sequential organ failure assessment score, including: P:F ratio; MAP or vasoactive treatment; creatinine or 24-h diuresis; platelet count; serum bilirubin; GCS.</description>
    <arm_group_label>Mortality outcome</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Medical record of adult patients in burn units during a period between January 2012 and
        December 2017
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients (age 18 and above) who admitted to burn unit during sampling period

        Exclusion Criteria:

          -  patients discharged or deceased less than 24 hours of admission

          -  patients referred to other hospital within 30 days admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rumah Sakit Cipto Mangunkusumo</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <reference>
    <citation>Wardhana A, Basuki A, Prameswara ADH, Rizkita DN, Andarie AA, Canintika AF. The epidemiology of burns in Indonesia's national referral burn center from 2013 to 2015. Burn Open. 2017;1(2):67-73.</citation>
  </reference>
  <reference>
    <citation>Queiroz LF, Anami EH, Zampar EF, Tanita MT, Cardoso LT, Grion CM. Epidemiology and outcome analysis of burn patients admitted to an Intensive Care Unit in a University Hospital. Burns. 2016 May;42(3):655-62. doi: 10.1016/j.burns.2015.08.002. Epub 2016 Jan 4.</citation>
    <PMID>26762620</PMID>
  </reference>
  <reference>
    <citation>Taofik S, Senapathi TGA, Wiryana M. Comparison Of Validity Apache II, SOFA And Customized Sequential Organ Failure Assessment (Csofa) For Predicting Non-Surgical Patient. J Anestesiol Indones. 2015;7(2):102-13.</citation>
  </reference>
  <reference>
    <citation>Sunaryo A, Redjeki IS, Bisri T. Perbandingan Validasi APACHE II dan SOFA Score untuk Memperkirakan Mortalitas Pasien yang Dirawat di Ruang Perawatan Intensif. Majalah Kedokteran Terapi Intensif. 2012;2(1):11-20.</citation>
  </reference>
  <reference>
    <citation>Andrias A, Hanafie A, Wijaya DW. Comparison of APACHE II, SOFA, and CSOFA Scoring System Validity as Mortality Predictor in ICU Patients in H. Adam Malik General Hospital. J Anestesi Perioper. 2017;5(1):17-23j.</citation>
  </reference>
  <reference>
    <citation>Bouch DC, Thompson JP. Severity scoring systems in the critically ill. Contin Educ Anaesth Crit Care Pain. 2008;8(5):181-5.</citation>
  </reference>
  <reference>
    <citation>Vincent JL, de Mendon√ßa A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on &quot;sepsis-related problems&quot; of the European Society of Intensive Care Medicine. Crit Care Med. 1998 Nov;26(11):1793-800.</citation>
    <PMID>9824069</PMID>
  </reference>
  <reference>
    <citation>Snell JA, Loh NH, Mahambrey T, Shokrollahi K. Clinical review: the critical care management of the burn patient. Crit Care. 2013 Oct 7;17(5):241. doi: 10.1186/cc12706. Review.</citation>
    <PMID>24093225</PMID>
  </reference>
  <reference>
    <citation>Jain A, Palta S, Saroa R, Palta A, Sama S, Gombar S. Sequential organ failure assessment scoring and prediction of patient's outcome in Intensive Care Unit of a tertiary care hospital. J Anaesthesiol Clin Pharmacol. 2016 Jul-Sep;32(3):364-8. doi: 10.4103/0970-9185.168165.</citation>
    <PMID>27625487</PMID>
  </reference>
  <reference>
    <citation>C√°rdenas-Turanzas M, Ensor J, Wakefield C, Zhang K, Wallace SK, Price KJ, Nates JL. Cross-validation of a Sequential Organ Failure Assessment score-based model to predict mortality in patients with cancer admitted to the intensive care unit. J Crit Care. 2012 Dec;27(6):673-80. doi: 10.1016/j.jcrc.2012.04.018. Epub 2012 Jul 2.</citation>
    <PMID>22762932</PMID>
  </reference>
  <reference>
    <citation>de Brito MR, Barros AG, Valler L, Cardoso FB, Gasparotto AP, Tiziani L, et al. Evaluation of Sequential Organ Failure Assessment (SOFA) Performance in Neurocritical Care Patients Overtime: A Retrospective Cohort Study. J Brain Disord. 2017;1(1):38-43.</citation>
  </reference>
  <reference>
    <citation>Nair R, Bhandary NM, D'Souza AD. Initial Sequential Organ Failure Assessment score versus Simplified Acute Physiology score to analyze multiple organ dysfunction in infectious diseases in Intensive Care Unit. Indian J Crit Care Med. 2016 Apr;20(4):210-5. doi: 10.4103/0972-5229.180041.</citation>
    <PMID>27303136</PMID>
  </reference>
  <reference>
    <citation>Cabr√© L, Mancebo J, Solsona JF, Saura P, Gich I, Blanch L, Carrasco G, Mart√≠n MC; Bioethics Working Group of the SEMICYUC. Multicenter study of the multiple organ dysfunction syndrome in intensive care units: the usefulness of Sequential Organ Failure Assessment scores in decision making. Intensive Care Med. 2005 Jul;31(7):927-33. Epub 2005 Apr 26.</citation>
    <PMID>15856171</PMID>
  </reference>
  <reference>
    <citation>Lorente JA, Vallejo A, Galeiras R, T√≥micic V, Zamora J, Cerd√° E, de la Cal MA, Esteban A. Organ dysfunction as estimated by the sequential organ failure assessment score is related to outcome in critically ill burn patients. Shock. 2009 Feb;31(2):125-31. doi: 10.1097/SHK.0b013e31817fc3ef.</citation>
    <PMID>18650779</PMID>
  </reference>
  <reference>
    <citation>Karlie J, Wardhana A. External Validation of Belgian Outcome of Burn Injury Score on Burned Patient In Burn Unit Cipto Mangunkusumo General Hospital. New Ropanasuri J Surg. 2017;2(1):90.</citation>
  </reference>
  <reference>
    <citation>Emara SS, Alzaylai AA. Renal failure in burn patients: a review. Ann Burns Fire Disasters. 2013 Mar 31;26(1):12-5.</citation>
    <PMID>23966893</PMID>
  </reference>
  <reference>
    <citation>Ibrahim AE, Sarhane KA, Fagan SP, Goverman J. Renal dysfunction in burns: a review. Ann Burns Fire Disasters. 2013 Mar 31;26(1):16-25.</citation>
    <PMID>23966894</PMID>
  </reference>
  <reference>
    <citation>Carson J, Goverman J, Fagan S. Acute renal failure in association with thermal injury. In: Herndon D, editor. Total Burn Care. 5th ed. Elsevier; 2018. p. 318-27.</citation>
  </reference>
  <reference>
    <citation>Nielson CB, Duethman NC, Howard JM, Moncure M, Wood JG. Burns: Pathophysiology of Systemic Complications and Current Management. J Burn Care Res. 2017 Jan/Feb;38(1):e469-e481. doi: 10.1097/BCR.0000000000000355. Review.</citation>
    <PMID>27183443</PMID>
  </reference>
  <reference>
    <citation>Enkhbaatar P, Sousse L, Cox R, Herndon D. The pathophysiology of inhalation injury. In: Herndon D, editor. Total Burn Care. 5th ed. Elsevier; 2018. p. 174-83.</citation>
  </reference>
  <reference>
    <citation>Marck RE, Montagne HL, Tuinebreijer WE, Breederveld RS. Time course of thrombocytes in burn patients and its predictive value for outcome. Burns. 2013 Jun;39(4):714-22. doi: 10.1016/j.burns.2013.01.015. Epub 2013 Mar 13.</citation>
    <PMID>23490002</PMID>
  </reference>
  <reference>
    <citation>Guo F, Wang X, Huan J, Liang X, Chen B, Tang J, Gao C. Association of platelet counts decline and mortality in severely burnt patients. J Crit Care. 2012 Oct;27(5):529.e1-7. doi: 10.1016/j.jcrc.2011.12.006. Epub 2012 Feb 1.</citation>
    <PMID>22300492</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 24, 2019</study_first_submitted>
  <study_first_submitted_qc>April 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2019</study_first_posted>
  <last_update_submitted>April 24, 2019</last_update_submitted>
  <last_update_submitted_qc>April 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Dita Aditianingsih</investigator_full_name>
    <investigator_title>MD, PhD, Anesthesiologist Consultant</investigator_title>
  </responsible_party>
  <keyword>Burn injury</keyword>
  <keyword>Mortality prediction</keyword>
  <keyword>SOFA score</keyword>
  <keyword>Organ failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

